EP3 Antibodies

Santa Cruz Biotechnology delivers a wide array of EP3 Antibodies for advanced research in pharmacology and cellular signaling. EP3 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The EP3 receptor, a subtype of the prostaglandin E receptor, plays a critical role in mediating the effects of prostaglandin, which regulates inflammation, pain, and various physiological processes. Understanding EP3 receptor function is essential for elucidating its involvement in numerous pathophysiological conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders. EP3 receptor research continues to reveal new insights into cellular mechanisms and potential therapeutic approaches. Investigating EP3 receptor expression and activity patterns helps researchers better understand its role in disease progression and treatment responses. Current studies focusing on EP3 receptor signaling pathways are uncovering promising therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for EP3 receptor research enable scientists worldwide to advance their understanding of disease mechanisms and develop innovative therapeutic strategies.